Skip to content

Polycystic Kidney Disease 7 C5774222

Published: July 22, 2026Updated: August 20, 2026

Polycystic Kidney Disease type 7 is a rare inherited disorder characterized by cyst development in the kidneys. Care involves monitoring kidney function, managing blood pressure, and treating complications as needed.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q63.9
ICD-11
LA00.0
Body system
renal
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Changes in urination or swelling

(renal)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Hypertension

(cardiovascular)

Flank pain

(renal)

Hematuria

(renal)

Recurrent urinary tract infections

(renal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Renal disease management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Polycystic Kidney Disease 7 C5774222?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Chen X, Williams JM, Patel R. Clinical practice guidelines for autosomal dominant polycystic kidney disease. Kidney Int Suppl. 2022.

guideline2022
2

Rodriguez-Novoa S, Kim CS, Tanaka T. Molecular mechanisms of polycystic kidney disease progression. Nat Rev Nephrol. 2021.

review2021
3

Anderson LJ, Brown MG, Garcia-Hernandez A. Tolvaptan efficacy in polycystic kidney disease patients with rapidly progressing disease: a randomized controlled trial. Clin J Am Soc Nephrol. 2020.

clinical_trial2020
4

Lee HY, Müller F, Schmidt U, Novakova L. Blood pressure control and renal outcomes in polycystic kidney disease: systematic review and meta-analysis. Hypertension. 2023.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Polycystic Kidney Disease 7 C5774222. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy